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While silica nanoparticles have enabled numerous industrial and medical applications,
their toxicological safety requires further evaluation. Macrophages are the major cell
population responsible for nanoparticle clearance in vivo. The prevailing macrophage
phenotype largely depends on the local immune status of the host. Whereas M1-
polarized macrophages are considered as pro-inflammatory macrophages involved
in host defense, M2 macrophages exhibit anti-inflammatory and wound-healing
properties, but also promote tumor growth. We employed different models of M1 and
M2 polarization: granulocyte-macrophage colony-stimulating factor/lipopolysaccharide
(LPS)/interferon (IFN)-γ was used to generate primary human M1 cells and macrophage
colony-stimulating factor (M-CSF)/interleukin (IL)-10 to differentiate M2 monocyte-
derived macrophages (MDM). PMA-differentiated THP-1 cells were polarized towards
an M1 type by LPS/IFN-γ and towards M2 by IL-10. Uptake of fluorescent silica
nanoparticles (Ø26 and 41 nm) and microparticles (Ø1.75 μm) was quantified. At the
concentration used (50 μg/ml), silica nanoparticles did not influence cell viability as
assessed by MTT assay. Nanoparticle uptake was enhanced in M2-polarized primary
human MDM compared with M1 cells, as shown by flow cytometric and microscopic
approaches. In contrast, the uptake of microparticles did not differ between M1 and
M2 phenotypes. M2 polarization was also associated with increased nanoparticle
uptake in the macrophage-like THP-1 cell line. In accordance, in vivo polarized M2-
like primary human tumor-associated macrophages obtained from lung tumors took up
more nanoparticles than M1-like alveolar macrophages isolated from the surrounding
lung tissue. In summary, our data indicate that the M2 polarization of macrophages
promotes nanoparticle internalization. Therefore, the phenotypical differences between
macrophage subsets should be taken into consideration in future investigations on
nanosafety, but might also open up therapeutic perspectives allowing to specifically
target M2 polarized macrophages.
Keywords: inflammation, mononuclear phagocyte system, phagocytosis, endocytosis, lung macrophages,
alveolar macrophage, tumor-associated macrophage, real-time RT-PCR
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Introduction
Numerous types of nanomaterials, such as quantum dots or sil-
ica, carbon, zinc oxide, and gold nanoparticles, have been shown
to induce inﬂammatory responses both in vitro and in vivo (Deng
et al., 2011; Autengruber et al., 2014; Kusaka et al., 2014; Roy et al.,
2014; Wu and Tang, 2014). Macrophages represent critical regu-
lators of inﬂammatory processes and also exhibit a high uptake
potential for nanoparticles (Sica and Mantovani, 2012; Diesel
et al., 2013; Klein et al., 2013; Amoozgar and Goldberg, 2014;
Kusaka et al., 2014). Therefore, the investigation of macrophage
responses upon nanoparticle exposure is highly relevant for the
prediction of potentially harmful eﬀects.
Most cellular models used so far to investigate nanoparticle-
associated inﬂammation do not take macrophage heterogeneity
into account. A study by Jones et al. (2013) recently reported that
the rate of nanoparticle clearance in vivo diﬀers largely between
mouse strains dependent on their preference for either Th1- or
Th2-responses. C57BL/6 mice preferentially produce T helper
type 1 (Th1) cytokines, such as interferon (IFN)-γ, whereas those
from Balb/c mice favor T helper type 2 (Th2) cytokine pro-
duction, e.g., interleukin (IL)-10. In addition to their distinct
T-cell responses, in vitro investigations have demonstrated that
macrophages from these mouse strains exert diﬀerent reactions
in response to the bacterial cell wall component and activator of
the innate immune response lipopolysaccharide (LPS; Watanabe
et al., 2004).
With reference to Th1/Th2 polarization, two distinct states of
polarized activation for macrophages have been suggested: the
classically activated (M1)macrophage phenotype and the alterna-
tively activated (M2) macrophage phenotype. M1 macrophages
act as eﬀector cells in Th1 responses, whereas M2 macrophages
appear to be involved in immunosuppression and tissue repair.
LPS and the Th1 cytokine IFN-γ polarize macrophages towards
the M1 phenotype associated with the production of large
amounts of pro-inﬂammatory mediators, such as tumor-necrosis
factor (TNF)-α, nitric oxide, IL-12, and IL-23, thereby promot-
ing pathogen clearance and antigen speciﬁc Th1 and Th17 cell
responses. In contrast, exposure of macrophages to the Th2
cytokines IL-4 or IL-10 induces an M2 phenotype character-
ized by the production of high levels of IL-10 and IL-1 receptor
antagonist and low expression of IL-12. These cells facilitate
parasite clearance and reduce inﬂammation, but are also consid-
ered to contribute to asthma exacerbations and tumor progres-
sion (Gordon and Mantovani, 2011; Sica and Mantovani, 2012;
Boorsma et al., 2013; Mills and Ley, 2014).
Using depletion strategies, Jones et al. (2013) demonstrated
that macrophages are involved in the enhanced clearance of
300 nm cylindrical PEG hydrogel nanoparticles observed in
Th2-prone mice. In accordance, macrophages isolated from Th1
strains showed a lower capacity than macrophages from Th2
strains to take up these nanoparticles. In vitro polarization led to
similar results, suggesting that macrophage polarization critically
aﬀects nanoparticle uptake.
Other factors inﬂuencing cellular uptake include nanoparticle
morphology, i.e., size and shape, and thematerials used (Albanese
et al., 2012; Kusaka et al., 2014; Truong et al., 2014). Therefore,
the ﬁndings by Jones et al. (2013) might not apply to other types
of nanoparticles.
Among diﬀerent nanomaterials, silica nanoparticles are widely
used in various applications, ranging from additives for plastics
or food to targeted drug carrier systems. Worldwide, 1.5 million
tons of amorphous silica nanoparticles are produced annually.
This huge production rate is even expected to rise due to growth
sectors such as energy and information technology as well as
nanomedicine (BMBF, 2013).
Despite the increasing number of applications for silica
nanoparticles, the inﬂuence of macrophage polarization on their
uptake and thereby their clearance has not been characterized yet.
Thus, we examined the uptake potential of diﬀerentially polar-
ized human macrophages for silica nanoparticles by employing
ﬂuorescently labeled particles.
Materials and Methods
Cell Culture
Human Monocyte-Derived Macrophages (MDM)
Buﬀy coats were obtained from healthy adult blood donors
(Blood Donation Center, Saarbrücken, Germany). The use of
humanmaterial for the isolation of primary cells was approved by
the local ethics committee (State Medical Board of Registration,
Saarland, Germany; permission no. 130/08). Monocytes were iso-
lated from buﬀy coats with CD14 microbeads (Miltenyi Biotec)
as suggested by the supplier. In brief, peripheral blood mononu-
clear cells (PBMC) were isolated by density gradient centrifuga-
tion using Pancoll (PAN Biotech). PBMC were washed in PBS
(phosphate buﬀered saline, Sigma–Aldrich) containing EDTA
(2 mM, Sigma–Aldrich) and remaining erythrocytes were lysed
in BD Pharm Lyse (BD Biosciences). After washing twice with
PBS/EDTA, monocytes were puriﬁed from PBMC using mag-
netic cell sorting with anti-CD14 microbeads (Miltenyi Biotec)
according to the manufacturer’s instructions, except that FCS
was used instead of BSA to prepare respective buﬀers. Monocyte
purity was >95% as assessed by CD14 expression (data not
shown).
For macrophage polarization, monocytes were cultured in 12-
well plates at a density of 0.5 × 106 cells per well for 5 days at
37◦C and 5% CO2 in Macrophage-SFM (Life Technologies) sup-
plemented with either 10 ng/ml human recombinant macrophage
colony-stimulating factor (M-CSF) or granulocyte-macrophage
colony-stimulating factor (GM-CSF; Miltenyi Biotec). Medium
was changed every other day. GM-CSF- or M-CSF-diﬀerentiated
macrophages (GM-Mφ/M-Mφ) were stimulated for another 40 h
or as indicated with 1 μg/ml LPS (Sigma–Aldrich) and 20 ng/ml
human recombinant IFN-γ or 200 ng/ml human recombinant IL-
10 (both from Miltenyi Biotec), respectively. All cytokines and
growth factors were dissolved in endotoxin-free water (Sigma–
Aldrich).
For particle uptake experiments, monocytes were cultured
in petri dishes (Ø60 mm) at a density of 6 × 106 cells per
dish for 4 days at 37◦C and 5% CO2 in Macrophage-SFM
(Life Technologies) supplemented with GM-CSF or M-CSF as
described above. On day 4, cells were detached from plates
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using PBS supplemented with 5 mM EDTA (Sigma–Aldrich) and
seeded into 24-well plates at a density of 1.5 × 105 cells/well.
On the next day, cells were stimulated with LPS/IFN-γ or IL-10
as described above. In all experiments comparing GM-M and
M-M, cells were generated from monocytes obtained from the
same donor.
Human Alveolar and Tumor-Associated Macrophages
(AM/TAM)
Alveolar macrophages (AM) and tumor-associated macrophages
(TAM) were isolated from human non-tumor lung tissue or
the respective tumor tissue obtained from patients undergo-
ing lung resection. The use of human material was reviewed
and approved by the local ethics committee (State Medical
Board of Registration, Saarland, Germany; permission no.
213/06). The informed consent of all participating subjects was
obtained.
For TAM isolation, tumor tissue was enzymatically digested
using a commercially available enzyme mix optimized for
the digestion of human tumors (human tumor dissociation
kit, Miltenyi Biotec). Additionally, mechanical dissociation was
performed before and during the digestion procedure using
the gentleMACS Octo Dissociator according to the manufac-
turer’s instructions. Cells were washed, resuspended in AM/TAM
medium (RPMI 1640, 5% FCS, 100 U/ml penicillin G, 100 μg/ml
streptomycin, 2 mM glutamine, Sigma–Aldrich) and incubated
at 37◦C and 5% CO2 for 0.5 h. Adherent cells were thor-
oughly washed with PBS (137 mM NaCl, 2.7 mM KCl, 10.1 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4), detached with accutase
(Sigma–Aldrich), and cultivated at a density of 0.5 × 106 cells
per well in a 12-well plate for 2–3 days.
Alveolar macrophages isolation was performed according to
a previously described method (Hoppstädter et al., 2010, 2012)
with minor modiﬁcations. After visible bronchi were removed,
the lung tissue was chopped and washed with 100–200 ml PBS.
Washing buﬀer was collected and AM were obtained by cen-
trifugation. Remaining erythrocytes were lysed by incubation
with hypotonic buﬀer (155 mM NH4Cl, 10 mM KHCO3, 1 mM
Na2EDTA). After washing and centrifugation, the cell pellet was
mock-digested and cells were seeded as described for TAM.
THP-1 Cells
THP-1 cells were grown in RPMI 1640 medium supplemented
with 10% FCS, penicillin (100 U/ml)/streptomycin (100 μg/ml)
and 2 mM glutamine as described previously (Kiemer et al., 2009;
Hoppstädter et al., 2012). Cells were diﬀerentiated by adding
PMA (30 ng/ml, Sigma–Aldrich). After 48 h, cells were stimulated
with LPS/IFN-γ or IL-10 as described for MDM.
Particle Synthesis and Characterization
Nanoparticle Synthesis
Fluorescent silica nanoparticles were prepared according to a
procedure described previously (Schumann et al., 2012). In brief,
25 nm particles (FD25) were synthesized by L-arginine catalyzed
hydrolysis of tetraethoxysilane (TEOS, Sigma–Aldrich) in a
biphasic water/cyclohexane system. Addition of Atto647N (Atto-
Tec) conjugated with (3-aminopropyl)triethoxysilane (APTES,
ABCR) and cysteic acid yielded ﬂuorescent nanoparticles with
a mean diameter of ∼25 nm. Further regrowth of these parti-
cles yielded ﬂuorescent silica nanoparticles with a mean diameter
of ∼41 nm (FD45). All particles were dialyzed against ultrapure
water, ﬁltered through 0.2 μm cellulose acetate membranes and
stored in sterile containers prior to the biological experiments to
ensure both sterility and the absence of pyrogens (Kucki et al.,
2014).
Transmission Electron Microscopy (TEM)
A CM 200 FEG microscope (Philips) transmission electron
microscope (TEM) was used to study particle size and morphol-
ogy. Samples were prepared by immersion of a 200 mesh carbon-
coated copper grid into the undiluted nanoparticle suspension.
TEM images were recorded on dried samples (12–24 h) and
analyzed using ImageJ software from the National Institutes of
Health (http://rsb.info.nih.gov/ij/) to estimate the mean particle
size and particle size distribution.
Hydrodynamic Diameter in Ultrapure Water
Dynamic light scattering (DLS) measurements were performed
at 25◦C using a Zetasizer Nano ZS (Malvern Instruments) and
a nanoparticle size analyser NPA (Nanotrac). Prior to mea-
surements, all particle suspensions were diluted with ultrapure
water (1:10 sample:water). The ﬁtting of correlation data was
performed using proprietary Malvern or Nanotrac software.
Hydrodynamic diameters represent the mean of three sets of at
least 10 sequentially performed measurements. Diameters were
derived by Gauss ﬁtting of volume-based particle size distribu-
tions using Origin 9.1 (Originlab).
Zeta Potential
The zeta potential was measured at 25◦C using a Zetasizer Nano
ZS (Malvern Instruments). Sample conductivity was adjusted by
addition of diluted (0.01 M) potassium chloride solution. Each
value represents the mean of three sets of at least 10 sequentially
performed measurements.
Elemental Analysis (ICP-OES)
The Si content was determined by ICP-OES measurements
(Ultima 2, Horiba Jobin Ivon) of the aqueous particle suspensions
(wavelength Si: 251.611 nm). Samples were diluted in ultrapure
water (1:1,000, v/v) prior to injection via a seaspray vaporizer
(pressure: 2.64 bar, ﬂow rate: 1.04 l/min).
Spectroscopic Characterization and Particle
Leaching
UV-Vis spectra were recorded using a Cary300Scan UV (Varian)
UV-Vis spectrometer for non-diluted samples in the range from
300 to 800 nm to determine the excitation maximum of the ﬂuo-
rescent particles. A Spex FluoroMax-3 ﬂuorescence spectrometer
was used to record ﬂuorescence spectra of diluted samples (1:100,
v/v). Leaching of non-covalently bound or loosely adsorbed ﬂu-
orescent dye at the particle surface and particle matrix was
investigated by extensive dialysis of the particles against ultrapure
water for at least 3 days. The ratio between initial maximum ﬂu-
orescence intensity at emission maximum and the particles after
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the experiment was used to calculate the degree of dye leaching
present in the sample.
Determination of Cell Viability
The MTT [3-(4,5-dimethyl-thiazol-2-)-2.5-diphenyl tetrazolium
bromide] colorimetric assay was used to ensure the usage of non-
toxic nanoparticle concentrations as described previously (Diesel
et al., 2013; Astanina et al., 2014; Ziaei et al., 2015) Brieﬂy, cul-
ture mediumwas replaced byMTT solution (0.5 mg/ml in culture
medium) after 24 h of nanoparticle exposure in medium con-
taining 5% FCS. After incubation for 2 h, the MTT solution
was removed and cells were solubilized in dimethyl sufoxide
(DMSO). Absorbance measurements were performed at 550 nm
with 630 nm as the reference wavelength using a microplate
reader (Tecan Sunrise). The cell viability index was calculated
relative to the untreated control and obtained from at least two
independent experiments.
Flow Cytometry
Expression of Intracellular and Surface Markers
Monocyte-derived macrophages were harvested using PBS con-
taining 5 mM EDTA (Sigma–Aldrich). Cells were resuspended
in MACS Buﬀer (PBS pH 7.2 containing 2 mM EDTA,
0.5% (w/v) BSA, and 0.09% (w/v) NaN3, Miltenyi Biotec).
All antibodies were obtained from Miltenyi Biotec and used
at concentrations recommended by the supplier. FcR recep-
tors were blocked using FcR Blocking Reagent (Miltenyi
Biotec). Cells were stained with the following antibodies:
anti-CD14 (PE, clone TÜK4), anti-CD80 (PE, Clone 2D10),
anti-HLA-DR, DP, DQ (FITC, clone REA332), anti-CD163
(FITC, clone GHI/61.1). Cells were analyzed using FACSCalibur
(BD Biosciences) and FlowJo software. Results are reported
as relative geometric mean of ﬂuorescence intensity (GMFI;
GMFI of speciﬁcally stained cells related to GMFI of isotype
controls).
To detect intracellular CD68 in AM and TAM, the washed
cells were ﬁxed for 10 min in 1% (w/v) paraformaldehyde
in PBS, pH 7.6, and then stained with anti-CD68 (PE, clone
Y1/82A) in saponin buﬀer (PBS containing 2.5% (v/v) bovine
calf serum, 0.05% (w/v) NaN3, and 0.2% (w/v) saponin) after
permeabilization for 10 min in saponin buﬀer and blocking for
30 min in 10% (v/v, diluted in saponin buﬀer) human AB serum
(PAA).
Particle Uptake
All particle treatments were performed in medium containing
5% FCS, as silica nanoparticles exposed to cells in the absence
of serum display a stronger adhesion to the cell membrane, a
higher internalization eﬃciency and increased toxicity (Lesniak
et al., 2012). In fact, the absence of proteins does not reﬂect the
in vivo situation. After incubation for 1 h with nanoparticles
(50 μg/ml) or 1.75 μmmicroparticles (Fluoresbrite carboxylated
YG microspheres, Polysciences, 100 particles/cell), macrophages
were washed two times with PBS and detached from plates
using PBS containing 5 mM EDTA. Cells were resuspended in
MACS buﬀer and examined on a FACSCalibur (BD Biosciences).
Results were analyzed using FlowJo software and are presented
as relative GMFI (mean ﬂuorescence intensity of particle-loaded
cells related tomean ﬂuorescence intensity of untreated controls).
RNA Isolation, Reverse transcription, and
Real-Time RT-PCR
Total RNA was extracted using the RNeasy plus mini kit
(Qiagen). 200 ng of total RNA were reverse transcribed in a
total volume of 20 μl using the High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) according to the man-
ufacturer’s instructions. The CFX96 TouchTM Real-Time PCR
Detection System (Bio-Rad) was used for real-time RT-PCR.
Primers and dual-labeled probes were obtained from Euroﬁns
MWG Operon. Primer and probe sequences were described
previously (Hoppstädter et al., 2010). Standards, from 60 to
0.00006 attomoles of the PCR product cloned into pGEMTeasy
(Promega), were run alongside the samples to generate a stan-
dard curve. All samples and standards were analyzed in trip-
licate. The PCR reaction mix consisted of 10x PCR buﬀer
(GenScript), either 2 or 8 mM dNTPs (GenScript), 3–9 mM
Mg2+, 500 nM sense, and antisense primers, either 2.5 or
1.5 pmol of the respective dual-labeled probe, and 2.5 U of
Taq DNA Polymerase (GenScript) in a total volume of 25 μl as
described in (Hoppstädter et al., 2010, 2012; Hahn et al., 2014).
The reaction conditions were 95◦C for 8 min followed by 40
cycles of 15 s at 95◦C, 15 s at a reaction dependent temperature
varying from 57 to 60◦C, and 15 s at 72◦C.
Fluorescence Microscopy
Cells were seeded into a SensoPlateTM 24-well glass-bottom plate
(Greiner Bio-One) at a density of 1.5 × 105 cells/well in 1 ml
Macrophage-SFM supplemented with the respective cytokines
and allowed to adhere overnight. Subsequently, cells were incu-
bated with nanoparticles at a concentration of 50 μg/ml or
1.75 μm microparticles (Fluoresbrite carboxylated YG micro-
spheres, Polysciences) at a ratio of 100 particles per cell in
medium containing 5% FCS. After 3 h at 37◦C, 5% CO2, cells
were washed three times with ice cold PBS and ﬁxed with ﬁx-
ing solution (Cell Biolabs) for 15 min at room temperature.
Subsequently, cells were washed three times with PBS again and
nuclei were counterstained with DAPI (Cell Biolabs) in PBS for
10 min. Cells were kept in PBS for microscopy analysis and
stored at 4◦C. Particle uptake was analyzed with anAxioObserver
Zeiss microscope (Carl Zeiss, Göttingen, Germany) equipped
with a MRM Axiocam at a 63× magniﬁcation using AxioVision
software.
Statistical Analysis
In general, each experiment was performed at least three times.
Data are presented as means + SEM. All data were distributed
normally, as determined by the Shapiro–Wilk test. Means of
two groups were compared with non-paired two-tailed Student’s
t-test. Means of more than two groups were compared by one
way ANOVA with Bonferroni’s post hoc test. Statistical signif-
icance was set at a p-value of <0.05, <0.01, or <0.001. Data
analysis was performed using Origin software (OriginPro 8.6G;
OriginLabs).
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Results
Polarization of Human Monocyte-Derived
Macrophages
Macrophages diﬀerentiated from monocytes by GM-CSF-
or M-CSF-treatment (GM-M/M-M) were stimulated with
LPS/IFN-γ or IL-10, respectively, to induce an M1 or M2 phe-
notype.
As reported in the literature (Rey-Giraud et al., 2012), GM-
Mwere characterized by high expression of HLAII, low expres-
sion of CD14, and the absence of CD163. Further polarization
with LPS/IFN-γ resulted in increased CD80 and HLAII sur-
face expression. M-M expressed higher levels of CD14 and
CD163 than GM-M or LPS/IFN-γ-treated GM-M. The addi-
tion of IL-10 to M-M led to higher expression of CD14 and
CD163, whereas HLAII and CD80 were only slightly expressed
(Figure 1A).
Analysis of cytokine mRNA expression revealed that lev-
els of TNF mRNA were elevated in LPS/IFN-γ treated GM-
M, correlating with the pro-inﬂammatory phenotype of these
macrophages (Figure 1B). On the other hand, IL10 mRNA was
induced by IL-10 treatment in M-M, suggesting a positive
feedback loop (Figure 1C).
Taken together, both surface marker and cytokine expression
were in accordance with reported data on MDM phenotypes
induced by LPS/IFN-γ (M1) or IL-10 (M2, also referred to as
M2c; Staples et al., 2007; Mosser and Edwards, 2008; Rey-Giraud
et al., 2012; Jones et al., 2013; Mills and Ley, 2014).
Nanoparticle Characterization and Toxicity
Particle characterization data are summarized in Table 1. Both
suspensions exhibited a similar and narrow size distribution
(PDITEM ∼ 0.08) derived from TEM (FD25: 25.5 ± 2 nm, FD45:
40.8 ± 3.2 nm, Figures 2A–D) and light scattering experiments
(FD25: 24.2 ± 5.5 nm, FD45: 39.1 ± 8.3 nm). Additionally,
a similar zeta potential of −30 mV (FD25: −31.2 mV, FD45:
−32.3 mV) was observed in aqueous suspension. Based on the
ICP-OES derived Si content of suspensions and the TEM derived
mean diameter, the particle number concentration of the stock
suspensions was calculated to be 833 nM (FD25) and 138 nM
(FD45). Both suspensions exhibited identical spectroscopic prop-
erties and could eﬃciently be excited at λEx = 647 nm with an
emission maximum at λEm = 660. The particles exhibited only a
low degree of dye leaching (<5–10%) and could easily be puriﬁed
by dialysis against ultrapure water.
From measurements using similar nanoparticle preparations,
it is known that the zeta potential is reduced in presence of
salt ions and even further in presence of serum by formation
of a protein corona. In addition, the presence of serum impairs
the determination of the hydrodynamic nanoparticle diameter of
small nanoparticles (Astanina et al., 2014). According to mea-
surements using larger nanoparticles, the tendency to form large
agglomerates increases with increasing particle concentration
(unpublished data). At the concentrations applied in this study,
particles are not expected to agglomerate extensively.
Viability tests employing the MTT assay showed no signiﬁ-
cant cytotoxicity of both nanoparticle preparations on GM-M,
M-M, THP-1 macrophages, and AM in concentrations up to
50μg/ml (Figures 2E,F and data not shown). Controls for unspe-
ciﬁc interactions of nanoparticles with the assay were performed
as previously described (Diesel et al., 2013; Astanina et al., 2014).
Uptake of Nanoparticles and Microparticles
in in vitro Polarized Macrophages
Particle uptake by M1 and M2 polarized primary human MDM
was assessed by ﬂow cytometry (Figures 3A,B). M1 and M2 cells
internalized 1.75 μm microspheres to a similar extent, as shown
by comparable values for relative GMFI. Likewise, no signiﬁcant
diﬀerence was observed between M1 and M2 cells regarding the
percentage of macrophages positive for particle-associated ﬂu-
orescence (63.8 ± 5.1% for M1 vs. 69.6 ± 3.3% for M2). In
contrast, both M1 and M2 macrophages were >98% positive for
particle-associated ﬂuorescence after incubation with nanoparti-
cles. GMFI values were signiﬁcantly higher in M2 macrophages
compared with M1 polarized cells, indicating that both 26 and
41 nm silica particles were taken up more eﬃciently in M2 cells.
Visualization of particle uptake by ﬂuorescence microscopy fur-
ther conﬁrmed these assumptions and indicated that nanoparti-
cles were in fact localized inside the cells and not merely attached
to their surface (Figure 3C).
In addition to MDM, the macrophage-like cell line THP-1 is
widely used to investigate the impact of M1 and M2 polariza-
tion on distinct cell functions (Tjiu et al., 2009; Chanput et al.,
2013). Therefore, we also analyzed nanoparticle uptake in these
cells after treatment with LPS/IFN-γ or IL-10 to induce an M1 or
M2 phenotype, respectively. As observed in primary MDM, the
uptake potential for nanoparticles was increased in M2-polarized
THP-1 macrophages when compared with M1 cells, as suggested
by signiﬁcantly increased GMFI values (Figure 4).
Nanoparticle Uptake in Primary Human
Alveolar Macrophages and
Tumor-Associated Macrophages
In general, TAM represent M2-like macrophages promoting
tumor cell proliferation, angiogenesis, matrix turnover, and
repression of adaptive immunity (Solinas et al., 2009). In con-
trast, AM are considered to exhibit a more pro-inﬂammatory,
M1-like phenotype (Hoppstädter et al., 2010). Therefore, we
hypothesized that the capacity to take up nanoparticles might
diﬀer between those two cell types. TAM were obtained after
digestion of tumor tissue from patients undergoing lung resec-
tion, whereas AMwere isolated from the surrounding non-tumor
lung tissue. AM populations mostly consisted of large, round
cells whereas TAM were more heterogenous in size and shape
(Figure 5A). Intracellular CD68, often used as a marker spe-
ciﬁc for macrophages (Holness and Simmons, 1993; Hoppstädter
et al., 2010), was detected in over 95% of the cells contained in AM
and TAM preparations, thereby identifying them as macrophages
(Figure 5B). The uptake of 26 nm silica particles was indeed
enhanced in TAM when compared to AM, as assessed by ﬂow
cytometry (Figure 5C), suggesting that our ﬁndings for in vitro
polarized macrophages also translate to the in vivo situation.
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FIGURE 1 | Characterization of in vitro polarized macrophages.
(A) Monocyte-derived macrophages (MDM) were either differentiated with
GM-CSF (GM-M) or M-CSF (M-M) and treated with LPS and IFN-γ
(M1) or IL-10 (M2), respectively. (A) Surface expression of CD14, CD163,
HLAII, and CD80 was analyzed by flow cytometry. Dark gray: isotype
control; light gray: specific staining. One representative histogram is
shown. Geometric mean of fluorescence intensity (GMFI) values are given
within graphs and represent the means ± SEM obtained from three
independent experiments with cells originating from different donors. (B,C)
GM-M and M-M were left untreated or treated with LPS/IFN-γ for 4 h
or IL-10 for 16 h as indicated. RNA was isolated and the expression of
TNF (B) and IL10 (C) mRNA was quantified by real-time RT-PCR and
normalized to ACTB. Data show means + SEM of independent
experiments performed in duplicate with cells from three different donors.
p-values were generated by one way ANOVA with Bonferroni’s post hoc
test. **p < 0.01, ***p < 0.001.
Discussion
The use of silica-based nanomaterials in commercial products,
e.g., as additives to food, cosmetics, varnishes, or printer toners, is
rapidly increasing. In addition, silica or silica coated engineered
nanoparticles have been suggested as promising candidates for
biomedical applications, such as gene transfection, drug delivery,
biosensing, and imaging applications (Ravi Kumar et al., 2004;
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TABLE 1 | Nanoparticle characterization data.
Silicon oxide NPs Sample
FD 25 FD 45
Particle size (nm) 25.5 ± 2 40.8 ± 3.2
Hydrodynamic diameter (nm) 24.2 ± 5.5 39.1 ± 8.3
Zetapotential (mV) −31.2 −32.3
Particle concentration (nmol/l) 833 138
λEx/λEm (nm) 647/661 647/661
Fluorescence label Atto647N Atto647N
Covalently attached >90% >95%
Surface -Si-O-H -Si-O-H
Knopp et al., 2009; Rosenholm et al., 2010; Probst et al., 2012;
Korzeniowska et al., 2013; Montalti et al., 2014). The growing
commercialization of nanotechnology products has raised con-
cerns about their safety. The physico-chemical properties of silica
nanoparticles that make them attractive for industrial use might
represent potential hazards to human health, due to an enhanced
ability to penetrate tissues or even cells and their interactions
with biomolecules. Investigations on their potential to induce cell
death or inﬂammation led to divergent results. Apart from the
composition and size of nanomaterials, the target cell type criti-
cally aﬀects intracellular responses and the degree of cytotoxicity
(Napierska et al., 2010; Sohaebuddin et al., 2010; Izak-Nau et al.,
2013).
After entering the body, nanoparticles are rapidly cleared by
macrophages and other cells of the mononuclear phagocyte sys-
tem (MPS; Yoo et al., 2010; Amoozgar and Goldberg, 2014).
Besides tissue macrophages present in every organ of the body,
the MPS includes committed precursors in the bone marrow
and circulating blood monocytes (Jenkins and Hume, 2014).
Nanoparticles entering tissues or circulating in the blood make
direct contact with various MPS cells. Previous studies have
shown that the MPS is responsible for the clearance of most
nanoparticles larger than 10 nm, regardless of their shape and
surface chemistry (Longmire et al., 2008).
Nanoparticle uptake by MPS cells can occur through vari-
ous pathways in macrophages, phagocytosis, and macropinocy-
tosis, as well as clathrin-, caveolae-, and scavenger receptor-
mediated endocytic pathways have been suggested to be involved
in nanoparticle internalization (Diesel et al., 2013; Kuhn et al.,
2014; Roy et al., 2014). Nanoparticle exposure can lead to
pro-inﬂammatory responses, most of which are associated
with macrophages. The avid uptake of nanoparticles by these
cells might make them more susceptible to particle overload
and cell death (Napierska et al., 2010; Sohaebuddin et al.,
2010). Thus, the characterization of nanoparticle uptake in
macrophages is an important step in the assessment of nanopar-
ticle toxicity.
In the present study, we demonstrated that macrophage
polarization inﬂuences particle uptake in primary human
macrophages and human macrophage-like THP-1 cells. M1
macrophages are considered to be more involved in inﬂamma-
tory and microbicidal processes, and have been shown to be
more phagocytic towards bacteria (Varin et al., 2010; Krysko
et al., 2011). In contrast, M2 macrophages are generally thought
to exert anti-inﬂammatory functions and to promote wound
healing. They might also be more involved in debris clear-
ance, since they exhibit a greater phagocytic activity towards cell
debris compared with M1 (Rey-Giraud et al., 2012), indicating
that the inﬂuence of macrophage polarization on phagocytosis
largely depends on the properties of the phagocytosed mate-
rial. Accordingly, phagocytosis has been suggested as a general
property of macrophages, but not a reliable predictor of M1
or M2 responses (Mills and Ley, 2014). In fact, we did not
detect any diﬀerences between primary M1 andM2macrophages
regarding the phagocytic uptake of latex microparticles. In line
with our ﬁndings, microparticle clearance has been reported to
be similar in Th1- and Th2-prone mouse strains (Jones et al.,
2013).
On the other hand, we observed a markedly increased uptake
of both 26 and 41 nm silica nanoparticles following M2 polar-
ization compared to M1 cells in primary as well as THP-1
macrophages. M2 macrophages have been shown to internal-
ize FITC-dextran and 300 nm PEG hydrogel nanoparticles more
eﬃciently when compared to M1 polarized cells, indicating that
M2 polarization leads to a higher endocytic capacity (Edin et al.,
2013). This might be due to increased expression of receptors
facilitating endocytosis, i.e., scavenger and lectin receptors, in
M2-polarized cells (Martinez et al., 2006; Rey-Giraud et al., 2012;
Jones et al., 2013). Furthermore, the Th1-biased mouse strain
C57BL/6 has been reported to clear nanoparticles more slowly
than the Th2-prone Balb/c strain, which might be mainly due to
the prevalence of M2 macrophages in Balb/c mice (Jones et al.,
2013).
The unique physical and chemical properties associated with
potentially detrimental eﬀects of nanoparticles on cells and tis-
sues might be beneﬁcial in the context of nanomedicine. In
fact, nanomaterials oﬀer many advantages, such as improved
bioavailability and feasibility of incorporation of both hydrophilic
and hydrophobic substances, and may be used in various
biomedical applications ranging from diagnostics to therapeutics
(Latterini and Amelia, 2009; Zhao et al., 2009; Chang et al., 2014;
Vijayanathan et al., 2014). Due to their hydrophilicity, stability in
physiological environment, ease of production, and relatively low
cost, silica nanoparticles display a great potential for biomedical
applications (Bitar et al., 2012).
However, rapid elimination from the systemic circulation by
cells from the MPS constitutes a major challenge for the applica-
tion of nanoparticles as intravenous drug delivery platforms, as it
greatly reduces the number of nanoparticles available at the target
site, thereby impairing the eﬃcacy of the drug (Yoo et al., 2010;
Amoozgar and Goldberg, 2014). At the same time, nanopar-
ticle accumulation in macrophages has been considered to be
an advantage for therapeutic strategies based on macrophage
reprogramming towards a stimulatory/destructive or a suppres-
sive/protective phenotype (Chellat et al., 2005).
A recently published meta-analysis revealed that the inter-
patient pharmacokinetic variability of nanoparticulate formu-
lations is higher compared with small molecule agents (Schell
et al., 2014). The patients’ immune status and thereby their
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FIGURE 2 | Nanoparticle characterization and cytotoxicity. (A,B) TEM
image of 25.5 ± 2.0 nm (FD25, A) and 40.8 ± 3.2 nm (FD45, B) fluorescent
silica particles. (C,D) Size distribution of FD25 (C) and FD45 (D) nanoparticles.
(E,F) Cell viability upon nanoparticle exposure as determined by MTT assay.
GM-M (E) or M-M (F) were treated with nanoparticles for 24 h at the
indicated concentrations. Data represent means + SEM from two independent
experiments performed at least in quadruplicate with cells originating from
different donors. Values obtained for untreated cells were set as 100%. p-values
were calculated by one way ANOVA with Bonferroni’s post hoc test.
***p < 0.001, compared with untreated cells.
prevailing macrophage phenotype can be inﬂuenced by various
immune-priming events such as allergies or infections (Sica and
Mantovani, 2012). Thus, our data suggest that the macrophage
phenotype might contribute to the high inter-individual phar-
macokinetic variability of nanoparticulate drugs, with analogous
implications for the clearance of potentially harmful nanoparti-
cles taken up from the environment.
We previously reported that distinct macrophage popula-
tions residing in the human lung exhibit diﬀerent pheno-
typic and functional characteristics: AM resembles inﬂammatory
M1 macrophages, whereas lung interstitial macrophages dis-
play a more regulatory phenotype (Hoppstädter et al., 2010).
Macrophages are also one of the major populations of inﬁl-
trating leukocytes in solid lung tumors. These TAM play an
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FIGURE 3 | Particle uptake in M1- and M2-polarized MDM.
(A,B) Macrophages were incubated for 1 h with FITC-labeled 1.75 μm latex
beads (100 beads/cell) or fluorescent nanoparticles (26 or 41 nm, 50 μg/ml) and
uptake efficiency was assessed by flow cytometry. (A) Representative
histograms are given. (B) GMFI values. Data represent means + SEM of three
independent experiments performed in duplicate or triplicate with cells derived
from different donors. p-values were generated by Student’s t-test. ***p < 0.001
compared with M1-polarized cells. (C) Representative images of M1 and M2
macrophages 3 h after particle addition. Green: microparticles, red:
nanoparticles, blue: nucleus, scale bar: 20 μm.
important role in tumor initiation, development, and metastasis.
TAM are considered to be a polarized M2-like macrophage pop-
ulation with potent immunosuppressive functions. High num-
bers of TAM are associated with a poor prognosis, accelerated
lymphangiogenesis, and lymph node metastasis (Sica et al., 2008;
Solinas et al., 2009; Ma et al., 2010). In the present study, we
compared the nanoparticle uptake capacity of human primary
TAM from non-small cell lung cancer tissue samples with AM
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FIGURE 4 | Particle uptake in M1- and M2-polarized THP-1
macrophages. (A,B,C) Cells were incubated for 1 h with fluorescent
nanoparticles (26 or 41 nm, 50 μg/ml) and uptake efficiency was assessed by
flow cytometry. (A) Representative histograms are given. (B,C) GMFI mean
values + SEM of three independent experiments performed in triplicate.
p-values were generated by Student’s t-test. ***p < 0.001 compared with
M1-polarized cells.
from non-tumor tissue. As observed for in vitro diﬀerentiated
M2 macrophages, the internalization of 26 nm silica nanoparti-
cles was clearly enhanced in TAM. Since TAM retain functional
plasticity, reprogramming TAM in order to eliminate their sup-
port for tumor growth or to induce cytotoxic activity has been
considered as a strategy to improve tumor therapy (Sica et al.,
2007; Stout et al., 2009; Chakraborty et al., 2012; Amoozgar and
Goldberg, 2014). Considering the high potential for nanoparti-
cle uptake observed in TAM, such therapeutic approaches might
beneﬁt from the use of nanoparticulate formulations.
In summary, our data suggest that the interaction of nanopar-
ticles with diﬀerentially polarized macrophages should be taken
into consideration when investigating the potentially toxic health
eﬀects of nanomaterials. What is more, the preferential uptake of
nanoparticles byM2-like macrophagesmight oﬀer new therapeu-
tic approaches aimed at targeting M2 macrophages.
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